Canadian REXULTI Compulsive Behaviours and Impulse Control Disorders Class Action
Reviewed by Marty Mikhail, lawyer licensed by the Law Society of OntarioLast verified How we verify
Status
Claims closedClaim deadline
Claims closed
The filing deadline for this claim has passed and filing is now closed. If you already submitted a claim, the claims administrator will contact you about next steps and payment.
Don't miss the next claim.
New Canadian class action claims open regularly. Join the monthly digest and you'll get a short list of new claims once a month. Free, and no account needed: a working email address is all it takes. Your email is never shared and you can unsubscribe with one click.
About this claim
If you were prescribed and took REXULTI between February 16, 2017 and August 23, 2025 and then developed a compulsive behaviour such as gambling, hypersexuality, binge eating, or compulsive shopping, or you are a family member of someone who did, you may be eligible for a cash payment.
Read more
REXULTI (generic name brexpiprazole) is a prescription medicine sold in Canada by Otsuka Canada Pharmaceuticals Inc. and Lundbeck Canada Inc. to treat certain mental health conditions. The class action alleges that the companies were negligent in failing to warn patients that REXULTI can cause, contribute to, or worsen compulsive behaviours and impulse control disorders, specifically compulsive gambling, hypersexuality, binge eating, and compulsive shopping.
On December 3, 2021 the Superior Court of Quebec authorized a national class action against the defendants, who deny the allegations. The parties reached a settlement that created a CDN $4.75 million fund, with about CDN $2.85 million available to pay compensation for approved claims. The settlement pays money to class members who developed these behaviours and to their eligible family members.
Claim types
This case covers more than one type of claim. Each has its own payment, proof requirements, and eligibility. Review the type that applies to you.
Psychological Harm
For class members who took REXULTI and experienced compulsive behaviours or impulse control disorders. Compensation is set at one of four levels (mild, moderate, severe, or residual catastrophic injury) based on how long the medication was taken and how severe the consequences were.
Proof: Documents required
Who qualifies
- Prescribed and took REXULTI between February 16, 2017 and August 23, 2025
- Experienced one or more compulsive behaviours (gambling, hypersexuality, binge eating, or compulsive shopping) while on or within 3 months of stopping REXULTI
Financial Loss
For class members with provable loss of income or employment, gambling losses, or loans incurred as a result of gambling caused or worsened by REXULTI. A total of CDN $570,000 has been set aside and will be shared pro rata among eligible claimants.
Payment: Share of the CDN $570,000 financial loss fund, distributed pro rata
Proof: Documents required
Who qualifies
- Qualify for a psychological harm claim
- Have provable gambling losses, income loss, or loan losses caused or worsened by REXULTI-related gambling
Family Class Member
For spouses, children, parents, grandparents, brothers, and sisters of a class member who is submitting a claim for psychological harm. Family members receive a fixed percentage of the class member's psychological harm payment.
Payment: Spouses 10%, parents and children 5% each, grandparents, brothers and sisters 2.5% each of the class member's psychological harm payment; total capped at $199,500.00
Proof: ID required
Who qualifies
- Are a spouse, child, parent, grandparent, brother, or sister of a class member
- The class member has not opted out and is submitting a claim for benefits
- Provide proof of the relationship to the class member
Claim Administrator
- MNP Ltd.
- Phone1 (855) 653-0027
- Websitehttps://www.rexulticlassactionsettlement.com
- MailMNP Ltd. – Class Actions Claims Administration 2000, 112 - 4th Avenue SW Calgary, AB, T2P 0H3
- Email[email protected]
Class Counsel
- Rochon Genova LLP
- MailRochon Genova, 900-121 Richmond St. W., Toronto, Ontario, M5H 2K1
- Toronto(416) 363-1867
- Toll-Free1-800-462-3864
- Email[email protected]
Class members can get free help with their claim from the claims administrator listed above.
Settlement Notices
Opting out
The deadline to opt out was and has passed. Opting out is no longer available. Class members who did not opt out remain in the class and are bound by the outcome.
Frequently Asked Questions
How much money can I receive?
Compensation depends on your claim. Psychological harm is paid at one of four levels (mild, moderate, severe, or residual catastrophic injury). A separate fund of CDN $570,000 covers financial losses and is shared pro rata. Eligible family members receive a fixed percentage of the class member's psychological harm payment (spouses 10%, parents and children 5% each, and grandparents, brothers and sisters 2.5% each).
What is the deadline to file a claim?
Completed Claim Packages must be received or postmarked no later than August 27, 2026. The original deadline of July 27, 2026, was extended to allow more class members an opportunity to submit a claim.
What proof is needed to file?
Claimants must attach prescription records and/or medical records showing they were prescribed and took REXULTI, along with the documents required for their claim type (for example medical records for treatment, or gambling and financial records for financial loss), and sign attestations confirming their experience.
How are claims filed?
Claimants complete and sign the Claim Form and mail or email the completed Claim Package with supporting documents to the Claims Administrator, MNP Ltd., in Calgary. The form can also be requested from the settlement website, or Class Counsel - Rochon Genova LLP.
What if I can not obtain my prescription or medical records?
The Claim Form includes a physician declaration and a missing documentation declaration. In extraordinary circumstances, a claimant who can not obtain the required records can provide a signed physician declaration and their own declaration explaining their reasonable best efforts to obtain them.